Skip to main content
Robert Naismith, MD, Neurology, Saint Louis, MO

RobertTNaismithMD

Neurology Saint Louis, MO

Neuroimmunology/Multiple Sclerosis

Professor, Neurology, Washington University School of Medicine

Dr. Naismith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Naismith's full profile

Already have an account?

  • Office

    4921 Parkview Pl
    # Dv
    Saint Louis, MO 63110
    Phone+1 314-362-1408
    Fax+1 314-747-1345

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2000 - 2003
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1998 - 2000
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1998

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2021 - 2026
  • MO State Medical License
    MO State Medical License 2000 - 2026
  • FL State Medical License
    FL State Medical License 2019 - 2021
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Turning Is an Important Marker of Balance Confidence and Walking Limitation in Persons with Multiple Sclerosis  
    Robert Naismith, MD, PLoS One

Press Mentions

  • NIH STTR Grant to Fast Track New Class of Pain Reliever Without Addiction or Toxicity
    NIH STTR Grant to Fast Track New Class of Pain Reliever Without Addiction or ToxicityOctober 21st, 2020
  • Oral Vumerity Easier on Gastrointestinal Tract Than Tecfidera, Phase 3 Trial Finds
    Oral Vumerity Easier on Gastrointestinal Tract Than Tecfidera, Phase 3 Trial FindsAugust 1st, 2019
  • Ibudilast Slows Brain Shrinkage in Progressive Multiple Sclerosis
    Ibudilast Slows Brain Shrinkage in Progressive Multiple SclerosisAugust 31st, 2018
  • Join now to see all

Grant Support

  • Diffusion Imaging Of Axonal Loss In The Optic NervesNational Institute Of Neurological Disorders And Stroke2007–2011